EUVIMEDEUVIMED entdecken
Crossref

In silico prediction of vaccine and diagnostic epitopes in Bartonella henselae MopA, VceA, and LemA proteins

Mervenur Güvendi, Muhammet Karakavuk, Aysu Değirmenci Döşkaya, Hüseyin Can, Mert Döşkaya, Adnan Yüksel Gürüz, Cemal Ün

BioImpacts · 07.09.2026 · 16 · 33561

DOI: 10.34172/bi.33561 ↗

Kurz gefasst

Fachartikel in der Zeitschrift BioImpacts, online erschienen am 07.09.2026. Verfasst von Mervenur Güvendi und 6 weiteren Autor:innen. Die Arbeit nennt 52 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Bartonella henselae represents a significant zoonotic threat for humans and has diagnostic challenges. In addition, any commercial vaccine isn’t currently available.

Methods

In this study, bioinformatics and immunoinformatics analyses were used to identify the vaccine and diagnostic epitopes of B. henselae MopA, VceA, and LemA proteins. Initially, the physicochemical properties, secondary structures, and antigenicity of the MopA, VceA, and LemA proteins from B. henselae were evaluated. Then, B and T-cell epitopes were predicted, and further analyzed in terms of antigenicity, allergenicity, solubility, and homology to the human proteome to determine suitable candidates for the final vaccine construct. The normal mode and molecular docking analyses were performed between the final vaccine construct and the TLR2 receptor. Finally, the immune response against the final vaccine construct was predicted.

Results

In silico analyses identified many B and T-cell epitopes with promising immunological and physicochemical properties. Among these, several epitopes showed high antigenicity scores (EINARVNQI, RAANALTVK, SVQIDTRTK and TSGQVISEDVGIKLE). In addition, the newly designed vaccine construct containing epitopes from MopA, Vce, and LemA proteins was found to interact with TLR2 and may stimulate adaptive immune responses.

Conclusion

The present study provides a comprehensive in silico epitope mapping of MopA, VceA, and LemA proteins of B. henselae. The identified epitopes and the vaccine construct can be candidate antigens for the development of serological tests and peptide vaccines. However, experimental studies are needed to validate their diagnostic performance and immunogenic potential.

Zitieren

APA

Güvendi, M., Karakavuk, M., Döşkaya, A. D., Can, H., Döşkaya, M., Gürüz, A. Y., & Ün, C. (2026). In silico prediction of vaccine and diagnostic epitopes in Bartonella henselae MopA, VceA, and LemA proteins. BioImpacts, 16, 33561. https://doi.org/10.34172/bi.33561

Vancouver

Güvendi M, Karakavuk M, Döşkaya AD, Can H, Döşkaya M, Gürüz AY, et al. In silico prediction of vaccine and diagnostic epitopes in Bartonella henselae MopA, VceA, and LemA proteins. BioImpacts. 2026;16:33561. doi:10.34172/bi.33561

BibTeX
@article{Gvendi2026,
  author = {Güvendi, Mervenur and Karakavuk, Muhammet and Döşkaya, Aysu Değirmenci and Can, Hüseyin and Döşkaya, Mert and Gürüz, Adnan Yüksel and Ün, Cemal},
  title = {In silico prediction of vaccine and diagnostic epitopes in Bartonella henselae MopA, VceA, and LemA proteins},
  journal = {BioImpacts},
  year = {2026},
  volume = {16},
  pages = {33561},
  doi = {10.34172/bi.33561}
}
Kostenlos starten →